The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
Open accessAbstract
This review covers the diverse topic of neuroendocrine neoplasms (NENs), a relatively rare and heterogeneous tumor type, comprising ~2% of all malignancies, with a prevalence of <200,000 in the United States, which makes it an orphan disease (Basu et al., 2010).1 For functional purposes, NENs are divided into two groups on the basis of clinical behavior, histology, and proliferation rate: well differentiated (low grade to intermediate grade) neuroendocrine tumors and poorly differentiated (high grade) neuroendocrine carcinoma (Bosman et al., 2010)2; this histological categorization/dichotomization is highly clinically relevant with respect to impact on treatment and prognosis even though it is not absolute since a subset of tumors with a low-grade appearance behaves similarly to high-grade lesions. Given the relative dearth of evidenced-based literature about this orphan disease as a whole (Modlin et al., 2008),3 since the focus of most articles is on particular anatomic subtypes of NENs (i.e., gastroenteropancreatic or pulmonary), the purpose of this review is to summarize the presentation, pathophysiology, staging, current standard of care treatments, and active areas of current research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of the Digestive System
Bosman, F. T. (2010) · Medical Entomology and Zoology · Cited by 5,041
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
Yao, J. C., Shah, M. H., Ito, T., Bohas, C. L., Wolin, E. M., Van Cutsem, E., Hobday, T. J., Okusaka, T., Capdevila, J., de Vries, E. G. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009290 · Cited by 2,876
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
Raymond, E., Dahan, L., Raoul, J.-L., Bang, Y.-J., Borbath, I., Lombard-Bohas, C., Valle, J., Metrakos, P., Smith, D., Vinik, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1003825 · Cited by 2,567
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Pathology and genetics of tumours of the lung , pleura, thymus and heart
Travis, W. D. (2004) · Cited by 1,955
Govindan, R., Page, N., Morgensztern, D., Read, W., Tierney, R., Vlahiotis, A., Spitznagel, E. L., & Piccirillo, J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4859 · Cited by 1,845
Self-citationGastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
Jiao, Y., Shi, C., Edil, B. H., de Wilde, R. F., Klimstra, D. S., Maitra, A., Schulick, R. D., Tang, L. H., Wolfgang, C. L., Choti, M. A., et al. (2011) · Science · doi:10.1126/science.1200609 · Cited by 1,717
An analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
Klimstra, D. S., Modlin, I. R., Coppola, D., Lloyd, R. V., & Suster, S. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ec124e · Cited by 1,072
Pavel, M. E., Hainsworth, J. D., Baudin, E., Peeters, M., Hörsch, D., Winkler, R. E., Klimovsky, J., Lebwohl, D., Jehl, V., Wolin, E. M., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61742-x · Cited by 1,058
Moertel, C. G., Lefkopoulo, M., Lipsitz, S., Hahn, R. G., & Klaassen, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202203260804 · Cited by 976
Ramage, J. K., Ahmed, A., Ardill, J., Bax, N., Breen, D. J., Caplin, M. E., Corrie, P., Davar, J., Davies, A. H., Lewington, V, et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300831 · Cited by 952
THE CLASSIFICATION OF CARCINOID TUMOURS
WILLIAMS, E. (1963) · The Lancet · doi:10.1016/s0140-6736(63)90951-6 · Cited by 885
Moertel, C. G., Kvols, L. K., O'Connell, M. J., & Rubin, J. (1991) · Cancer · doi:10.1002/1097-0142(19910715)68:2<227::aid-cncr2820680202>3.0.co;2-i · Cited by 840
Strosberg, J. R., Fine, R. L., Choi, J., Nasir, A., Coppola, D., Chen, D., Helm, J., & Kvols, L. (2011) · Cancer · doi:10.1002/cncr.25425 · Cited by 766
The diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674 · cited 2×
“The neuroendocrine (NE) system includes endocrine glands, such as the pituitary, the parathyroids, and the NE adrenal, as well as endocrine islet tissue embedded within glandular tissue (thyroid or pancreatic) and scattered cells in the exocrine parenchyma, such as endocrine cells of the digestive and respiratory trac…”
BackgroundMoertel, C. G., Hanley, J. A., & Johnson, L. A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198011203032101 · Cited by 659
Rindi, G., Luinetti, O., Cornaggia, M., Capella, C., & Solcia, E. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90266-f · Cited by 644
Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia
Verner, J. V., & Morrison, A. B. (1958) · The American Journal of Medicine · doi:10.1016/0002-9343(58)90075-5 · Cited by 636
Mishima, S., Nozaki, Y., Mikami, S., Kihira, E., Iikura, M., Koketsu, R., Sugiyama, H., Masuda, T., Kaname, H., Egami, Y., et al. (2015) · Case Reports in Gastroenterology · doi:10.1159/000381140 · Cited by 631
Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
Kulke, M. H., Lenz, H.-J., Meropol, N. J., Posey, J., Ryan, D. P., Picus, J., Bergsland, E., Stuart, K., Tye, L., Huang, X., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9020 · Cited by 623
Kouvaraki, M. A., Ajani, J. A., Hoff, P., Wolff, R., Evans, D. B., Lozano, R., & Yao, J. C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.024 · Cited by 607
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
Mitry, E., Baudin, E., Ducreux, M., Sabourin, J.-C., Rufié, P., Aparicio, T., Lasser, P., Elias, D., Duvillard, P., Schlumberger, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690325 · Cited by 496
Temozolomide as Monotherapy Is Effective in Treatment of Advanced Malignant Neuroendocrine Tumors
Ekeblad, S., Sundin, A., Janson, E. T., Welin, S., Granberg, D., Kindmark, H., Dunder, K., Kozlovacki, G., Örlefors, H., Sigurd, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2053 · Cited by 473
Neuroendocrine Neoplasms of the Lung: A Prognostic Spectrum
Asamura, H., Kameya, T., Matsuno, Y., Noguchi, M., Tada, H., Ishikawa, Y., Yokose, T., Jiang, S.-X., Inoue, T., Nakagawa, K., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.1202 · Cited by 468
Pape, U.-F., Perren, A., Niederle, B., Gross, D., Gress, T., Costa, F., Arnold, R., Denecke, T., Plöckinger, U., Salazar, R., et al. (2012) · Neuroendocrinology · doi:10.1159/000335629 · Cited by 465
Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral center
Janson, E. T., Holmberg, L., Stridsberg, M., Eriksson, B., Theodorsson, E., Wilander, E., & öberg, K. (1997) · Annals of Oncology · doi:10.1023/a:1008215730767 · Cited by 455
Neuroendocrine Tumors of the Lung: An Update
Rekhtman, N. (2010) · Archives of Pathology and Laboratory Medicine · doi:10.5858/2009-0583-rar.1 · Cited by 445
Gastric Carcinoids and Neuroendocrine Carcinomas: Pathogenesis, Pathology, and Behavior
Rindi, G., Bordi, C., Rappel, S., La Rosa, S., Stolte, M., & Solcia, E. (1996) · World Journal of Surgery · doi:10.1007/s002689900026 · Cited by 433
Fink, G., Krelbaum, T., Yellin, A., Bendayan, D., Saute, M., Glazer, M., & Kramer, M. R. (2001) · Chest · doi:10.1378/chest.119.6.1647 · Cited by 415
Yao, J. C., Phan, A., Hoff, P. M., Chen, H. X., Charnsangavej, C., Yeung, S.-C. J., Hess, K., Ng, C., Abbruzzese, J. L., & Ajani, J. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.6374 · Cited by 414
Epidemiology of Neuroendocrine Tumours
Taal, B. G., & Visser, O. (2004) · Neuroendocrinology · doi:10.1159/000080731 · Cited by 381
Neuroendocrine Tumors, Version 1.2015
Kulke, M. H., Shah, M. H., Benson, A. B., Bergsland, E., Berlin, J. D., Blaszkowsky, L. S., Emerson, L., Engstrom, P. F., Fanta, P., Giordano, T., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0011 · Cited by 360
Strosberg, J. R., Coppola, D., Klimstra, D. S., Phan, A. T., Kulke, M. H., Wiseman, G. A., & Kvols, L. K. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ebb56f · Cited by 359
Tang, L. H., Untch, B. R., Reidy, D. L., O'Reilly, E., Dhall, D., Jih, L., Basturk, O., Allen, P. J., & Klimstra, D. S. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0548 · Cited by 352
Gastroenteropancreatic high‐grade neuroendocrine carcinoma
Sorbye, H., Strosberg, J., Baudin, E., Klimstra, D. S., & Yao, J. C. (2014) · Cancer · doi:10.1002/cncr.28721 · Cited by 347
Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms
Klöppel, G. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0013 · Cited by 336
Advances in neuroendocrine lung tumors
Travis, W. D. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq380 · Cited by 327
Kulke, M. H., Siu, L. L., Tepper, J. E., Fisher, G., Jaffe, D., Haller, D. G., Ellis, L. M., Benedetti, J. K., Bergsland, E. K., Hobday, T. J., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.2056 · Cited by 304
Carcinoids (Argentaffin-Cell Tumors) and Nerve Hyperplasia of the Appendicular Mucosa.
Masson, P. (1928) · PubMed · Cited by 302
Welin, S., Sorbye, H., Sebjornsen, S., Knappskog, S., Busch, C., & Öberg, K. (2011) · Cancer · doi:10.1002/cncr.26124 · Cited by 288
Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update
Rosa, S. L., Marando, A., Sessa, F., & Capella, C. (2012) · Cancers · doi:10.3390/cancers4010011 · Cited by 287
Öberg, K., Funa, K., & Alm, G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198307213090301 · Cited by 275
Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
Harris, A. G. (1994) · Gut · doi:10.1136/gut.35.3_suppl.s1 · Cited by 266
Long-Term Serotonin Administration Induces Heart Valve Disease in Rats
Gustafsson, B. I., Tømmerås, K., Nordrum, I., Loennechen, J. P., Brunsvik, A., Solligård, E., Fossmark, R., Bakke, I., Syversen, U., & Waldum, H. (2005) · Circulation · doi:10.1161/01.cir.0000159356.42064.48 · Cited by 257
Eriksson, B., Klöppel, G., Krenning, E., Ahlman, H., Plöckinger, U., Wiedenmann, B., Arnold, R., Auernhammer, C., Körner, M., Rindi, G., et al. (2008) · Neuroendocrinology · doi:10.1159/000111034 · Cited by 254
Arnold, R., Rinke, A., Klose, K.-J., Müller, H.-H., Wied, M., Zamzow, K., Schmidt, C., Schade-Brittinger, C., Barth, P., Moll, R., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00481-7 · Cited by 254
Carcinoid tumour of the appendix
Goede, A. C., Caplin, M. E., & Winslet, M. C. (2003) · British Journal of Surgery · doi:10.1002/bjs.4375 · Cited by 238
Metastatic Carcinoid Tumors: A Clinical Review
Zuetenhorst, J. M., & Taal, B. G. (2005) · The Oncologist · doi:10.1634/theoncologist.10-2-123 · Cited by 237
Kölby, L., Persson, G., Franzén, S., & Ahrén, B. (2003) · British Journal of Surgery · doi:10.1002/bjs.4149 · Cited by 222
Update in Pulmonary Carcinoid Tumors: A Review Article
Hage, R., de la Rivière, A. B., Seldenrijk, C. A., & van den Bosch, J. M. M. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.09.019 · Cited by 197
Somatostatin analogue scintigraphy in carcinoid tumours
Kwekkeboom, D., Krenning, E., Bakker, W., Oei, H. Y., Kooij, P. M., & Lamberts, S. J. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00169802 · Cited by 185
Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms
Grozinsky-Glasberg, S., Shimon, I., Korbonits, M., & Grossman, A. B. (2008) · Endocrine Related Cancer · doi:10.1677/erc-07-0288 · Cited by 183
Ramanathan, R. K., Cnaan, A., Hahn, R. G., Carbone, P. P., & Haller, D. G. (2001) · Annals of Oncology · doi:10.1023/a:1011632713360 · Cited by 181
Schurr, P. G., Strate, T., Rese, K., Kaifi, J. T., Reichelt, U., Petri, S., Kleinhans, H., Yekebas, E. F., & Izbicki, J. R. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000232556.24258.68 · Cited by 178
Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis.
Gb, T., van Heerden, J. A., Jk, M., Schutt, A. J., Dm, I., & Carney, J. A. (1985) · PubMed · Cited by 171
Carcinoid tumors of the lung: Do atypical features require aggressive management?
Marty-Ané, C.-H., Costes, V., Pujol, J.-L., Alauzen, M., Baldet, P., & Mary, H. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(94)00630-p · Cited by 167
Genetic and epigenetic drivers of neuroendocrine tumours (NET)
Domenico, A. D., Wiedmer, T., Marinoni, I., & Perren, A. A. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0012 · Cited by 160
Prognostic factors in neuroendocrine lung tumors: a Spanish multicenter study
Garcı́a-Yuste, M., Matilla, J. M., Alvarez-Gago, T., Duque, J. L., Heras, F., Cerezal, L. J., & Ramos, G. (2000) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(00)01369-2 · Cited by 158
Clinical significance of blood chromogranin A measurement in neuroendocrine tumours
Seregni, E. C., Ferrari, L., Bajetta, E., Martinetti, A., & Bombardieri, E. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s69 · Cited by 150
Lévy-Bohbot, N., Merle, C. S., Goudet, P., et al. (2004) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(04)95184-6 · Cited by 149
Soga, J., & Yakuwa, Y. (1999) · PubMed · Cited by 146
Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
Kwekkeboom, D. J., & Krenning, E. P. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.09.009 · Cited by 131
The expanding role of somatostatin analogs in the management of neuroendocrine tumors.
Wolin, E. M. (2012) · Europe PMC (PubMed Central) · Cited by 126
Maroun, J. A., Kocha, W., Kvols, L. K., Bjarnason, G. A., Chen, E., Germond, C. J., Hanna, S. S., Poitras, P., Rayson, D., Reid, R. H., et al. (2006) · Current Oncology · doi:10.3390/curroncol13020006 · Cited by 117
Somatostatin and somatostatin analogues: diagnostic and therapeutic uses
de Herder, W. W., & Lamberts, S. W. J. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200201000-00010 · Cited by 115
Ardill, J. E. S., & Erikkson, B. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100459 · Cited by 103
Targeting the mTOR Signaling Pathway in Neuroendocrine Tumors
Chan, J. A., & Kulke, M. H. (2014) · Current Treatment Options in Oncology · doi:10.1007/s11864-014-0294-4 · Cited by 99
Farrell, J. M., Pang, J. C., Kim, G., & Tabatabai, Z. L. (2014) · Cancer Cytopathology · doi:10.1002/cncy.21457 · Cited by 99
Bousquet, C., Lasfargues, C., Chalabi‐Dchar, M., Moatassim-Billah, S., Susini, C., Vezzosi, D., Caron, P. J., & Pyronnet, S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2088 · Cited by 97
Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects.
Rajamannan, N. M., Caplice, N. M., Anthikad, F., Sebo, T. J., Orszulak, T. A., Wd, E., Tajik, J. A., & Schwartz, R. S. (2001) · PubMed · Cited by 96
The origin of neuroendocrine tumors and the neural crest saga
Rosaí, J. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.166 · Cited by 95
The Management of Neuroendocrine Tumours: Current and Future Medical Therapy Options
Öberg, K. E. (2011) · Clinical Oncology · doi:10.1016/j.clon.2011.08.006 · Cited by 90
The Medicinal Chemistry of Imidazotetrazine Prodrugs
Moody, C., & Wheelhouse, R. T. (2014) · Pharmaceuticals · doi:10.3390/ph7070797 · Cited by 88
Current Concepts on Gastric Carcinoid Tumors
Nikou, G. C., & Angelopoulos, T. P. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/287825 · Cited by 78
Clinical Presentation and Diagnosis of Neuroendocrine Tumors
Vinik, A. I., & Chaya, C. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.08.006 · Cited by 78
Vollbrecht, C., Werner, R., Walter, R. F. H., Christoph, D. C., Heukamp, L. C., Peifer, M., Hirsch, B., Burbat, L., Mairinger, T., Schmid, K. W., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.397 · Cited by 74
Treatment of Liver Metastases in Patients with Neuroendocrine Tumors: A Comprehensive Review
Harring, T. R., Nguyen, N. T. N., Goss, J. A., & O'Mahony, C. A. (2011) · International Journal of Hepatology · doi:10.4061/2011/154541 · Cited by 69
Perioperative Management of Selected Endocrine Disorders
Graham, G. W., Unger, B., & Coursin, D. B. (2000) · International Anesthesiology Clinics · doi:10.1097/00004311-200010000-00004 · Cited by 69
Molecular Profiling of Pancreatic Neuroendocrine Tumors in Sporadic and Von Hippel-Lindau Patients
Speisky, D., Ducès, A., Bièche, I., Rebours, V., Hammel, P. R., Sauvanet, A., Richard, S., Bédossa, P., Vidaud, M., Murat, A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2759 · Cited by 68
Pellagra and the Carcinoid Syndrome
Castiello, R. J., & Lynch, P. J. (1972) · Archives of Dermatology · doi:10.1001/archderm.1972.01620070046016 · Cited by 62
Clinical Presentation and Management of Carcinoid Tumors
Kulke, M. H. (2007) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2007.04.004 · Cited by 60
Effect of cigarette smoking on major histological types of lung cancer in men
Khuder, S., Dayal, H. H., Mutgi, A. B., Willey, J. C., & Dayal, G. (1998) · Lung Cancer · doi:10.1016/s0169-5002(98)00068-3 · Cited by 60
Biesma, B., Willemse, P., Mulder, N., Verschueren, R. C. J., Kema, I., de Bruijn, H. W. A., Postmus, P. E., Sleijfer, D., & de Vries, E. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.372 · Cited by 59
Rare endocrine tumours of the GI tract
Doherty, G. M. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.05.004 · Cited by 54
Multidisciplinary management of advanced lung neuroendocrine tumors.
Filosso, P. L., Ferollà, P., Guerrera, F., Ruffini, E., Travis, W. D., Rossi, G., Lausi, P. O., & OLIARO, A. (2015) · PubMed · doi:10.3978/j.issn.2072-1439.2015.04.20 · Cited by 51
Targeted Therapies in Neuroendocrine Tumors (NET): Clinical Trial Challenges and Lessons Learned
Yao, J. C., Reidy‐Lagunes, D. L., & Kulke, M. H. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0434 · Cited by 51
Diagnostic, surgical and medical aspect of the midgut carcinoids
de Vries, H., Verschueren, R. C. J., Willemse, P. H. B., Kema, I. P., & de Vries, E. G. E. (2002) · Cancer Treatment Reviews · doi:10.1053/ctrv.2001.0239 · Cited by 50
Abdominal Surgery in Patients with Midgut Carcinoid Tumors
Åkerström, G., Makridis, C., & Johansson, H. (1991) · Acta Oncologica · doi:10.3109/02841869109092416 · Cited by 48
Boyce, M. J., & Thomsen, L. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1009941 · Cited by 43
The safety of available treatments options for neuroendocrine tumors
Faggiano, A., Calzo, F. L., Pizza, G., Modica, R., & Colao, A. A. L. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1354984 · Cited by 43
Diagnosis and Treatment of Neuroendocrine Lung Tumors
Escuín, J. S. D. C. (2014) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2014.06.014 · Cited by 42
Diagnóstico y tratamiento de los tumores pulmonares neuroendocrinos
Escuín, J. S. D. C. (2014) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2014.02.004 · Cited by 40
Appendiceal neuroendocrine tumors: Recent insights and clinical implications
Grınıatsos, J. (2010) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v2.i4.192 · Cited by 39
Neuroendocrine Carcinoma of the Colon and Rectum
Kim, D. H., Lee, W. Y., Yun, H. R., Choi, Y. C., Cho, Y. B., Yun, S. H., Kim, H. C., & Chun, H.-K. (2009) · Journal of the Korean Society of Coloproctology · doi:10.3393/jksc.2009.25.1.46 · Cited by 35
Glucagonoma syndrome: a case report
Castro, P. G., de León, A. M., Trancón, J. E. G., Martínez, P. Á., Pérez, J. A. Á., Fernández, J. C. F., Bernardo, C. M. G., Barneo, L., & González, J. J. (2011) · Journal of Medical Case Reports · doi:10.1186/1752-1947-5-402 · Cited by 35
Chou, W., Chen, J., Hung, Y., Hsu, J., Chen, T., Sun, C., Lu, C., & Hwang, T. (2014) · PubMed · Cited by 34
The term "carcinoid" is a misnomer: the evidence based on local invasion
Soga, J. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-15 · Cited by 33
Familial syndromes associated with neuroendocrine tumours
Gut, P., Komarowska, H., Czarnywojtek, A., Waligórska‐Stachura, J., Bączyk, M., Ziemnicka, K., Fischbach, J., Wrotkowska, E., & Ruchała, M. (2015) · Współczesna Onkologia · doi:10.5114/wo.2015.52710 · Cited by 33
Sharma, J., Duque, M., & Saif, M. W. (2013) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x13498808 · Cited by 30
Saif, M. W., Kotteas, E. A., & Syrigos, K. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s72155 · Cited by 29
Nikou, G. C., Toubanakis, C., Nikolaou, P., Giannatou, E., Marinou, K., Safioleas, M. C., & Karamanolis, D. G. (2005) · PubMed · Cited by 28
Scalettar, B. A., Jacobs, C. L., Fulwiler, A. L., Prahl, L. S., Simon, A., Hilken, L., & Lochner, J. E. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20984 · Cited by 28
Carcinoid syndrome and serotonin: Therapeutic effects of ketanserin
Robertson, J. I. (1990) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00053427 · Cited by 27
Liu, E. V., Marincola, P., & Öberg, K. (2013) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x13496970 · Cited by 22
Strosberg, J. (2013) · Endocrine Practice · doi:10.4158/ep13262.ra · Cited by 18
Clinical presentation in insulinoma predicts histopathological tumour characteristics
Wolf, P. S., Winhofer, Y., Smajis, S., Anderwald, C. H., Scheuba, C., Niederle, B., Gessl, A., Luger, A., Krebs, M., & Koperek, O. (2015) · Clinical Endocrinology · doi:10.1111/cen.12777 · Cited by 15
Carter, C. A., Degesys, A., Oronsky, B. T., Scicinski, J. J., Caroen, S. Z., Oronsky, A. L., Reid, T. R., Cabrales, P., & Roswarski, J. (2015) · Case Reports in Oncology · doi:10.1159/000441775 · Cited by 14
Self-citationKotteas, E. A., Syrigos, K., & Saif, M. W. (2016) · Dove Medical Press (Taylor and Francis Group) · Cited by 13
Are Neuroendocrine Tumors Going Mainstream?
Kulke, M. H. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.3884 · Cited by 12
Nojima, H., Seike, K., Kosugi, C., Shida, T., Koda, K., Oda, K., Kamata, S., Ishikura, H., & Miyazaki, M. (2010) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-8-29 · Cited by 10
Netter-1: First Pivotal Phase III Study Evaluating 177Lu-Dotatate in Midgut Neuroendocrine Tumours
Sierra, M. L., Kwekkeboom, D. J., Mariani, M. F., Bodei, L., Santoro, P., & Krenning, E. P. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu345.34 · Cited by 1
Cited by
Notch signaling pathway: architecture, disease, and therapeutics
Zhou, B., Lin, W., Long, Y., Yang, Y., Zhang, H., Wu, K., & Chu, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00934-y · Cited by 1,114
177 Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors
Das, S., Al-Toubah, T., El-Haddad, G., & Strosberg, J. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1685381 · Cited by 135
“Gastroenteropancreatic (GEP) NETs represent the most common subtype of well-differentiated NETs, comprising more than 70% of these neoplasms [2].”
BackgroundPreclinical evaluation of [225Ac]Ac-DOTA-TATE for treatment of lung neuroendocrine neoplasms.
Tafreshi, N. K., Pandya, D. N., Tichacek, C. J., Budzevich, M. M., Wang, Z., Reff, J. N., Engelman, R. W., Boulware, D. C., Chiappori, A. A., Strosberg, J. R., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05315-1 · Cited by 50
Metadata
- Authors
- Oronsky, B., Ma, P. C., Morgensztern, D., & Carter, C. A.
- Venue
- Neoplasia
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 19
- Issue
- 12
- Pages
- 991-1002
- ISSN
- 1476-5586 (ISSN-L)
- OpenAlex
- W2766513655
- Cited by
- 763
- References
- 113
- FWCI
- 28.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.